Mucormycosis coinfection and Covid-19 – 2021 scenario: a scope review
DOI:
https://doi.org/10.33448/rsd-v11i5.28611Keywords:
Mucormycosis; Covid-19; Teaching; Coinfection.Abstract
The Covid-19 disease became a pandemic in 2019, starting in China. This disease is being related to opportunistic infections, mainly fungal. One of these co-infections refers to the association with mucormycosis. Objective: In this sense, this study was carried out to evaluate the information available in the literature on the subject and to detect possible clinical conducts. Methodology: For this, the scope review methodology was used to gather information about possible treatments and clinical procedures related to this double infection. Results: 350 articles were found and at the end 13 articles were included in the analysis. Close follow-up of the patients was identified as the clinical procedure to be adopted, in order to identify any facial necrosis, and liposomal amphotericin B was identified as treatment. Conclusion: This knowledge helps the SUS to set up care strategies and robust clinical protocols in relation to this co-infection, which is still little known, as observed in the current literature.
References
Arana, C., Ramírez, R.E.C., Xipell, M., et al. (2021). Mucormycosis associated with covid19 in two kidney transplant patients. Transpl Infect Dis. https://doi: 10.1111/tid.13652. Epub ahead of print. PMID: 34038014.
Arksey H. & O’Malley L. (2005). Scoping studies: towards a methodological framework. Int J Soc Res Methodol.8(1):19-32
Bayram, N., Ozsaygılı, C., Sav, H., et al. (2021). Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. https://doi: 10.1007/s10384-021-00845-5. Epub ahead of print. PMID: 34057620; PMCID: PMC8165350.
Bhatt, K., Agolli, A., Patel, M.H., et al. (2021). High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova). https://doi: 10.15190/d.2021.5. PMID: 34036149; PMCID: PMC8137279.
Garg, D., Muthu, V., Sehgal, I.S., et al. (2021). Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia. https://doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5. PMID: 33544266; PMCID: PMC7862973.
Honavar, S.G. (2021). Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. Indian J Ophthalmol. https://doi: 10.4103/ijo.IJO_1165_21. PMID: 34011699.
Kanwar, A., Jordan, A., Olewiler, S., et al. (2021). A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19. J Fungi (Basel). https://doi: 10.3390/jof7030174. PMID: 33670842; PMCID: PMC7997212.
Khatri, A., Chang, K.M., Berlinrut, I., et al. (2021) Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature. J Mycol Med. https://doi: 10.1016/j.mycmed.2021.101125. Epub 2021 Apr 2. PMID: 33857916; PMCID: PMC8017948.
Krishna, D.S., Raj, H., Kurup, P., et al. (2021). Maxillofacial Infections in Covid-19 Era-Actuality or the Unforeseen: 2 Case Reports. Indian J Otolaryngol Head Neck Surg. https://doi: 10.1007/s12070-021-02618-5. Epub ahead of print. PMID: 34026593; PMCID: PMC8127475.
Kubin, C. J., McConville, T. H., Dietz, D., et al. (2021). Characterization of Bacterial and Fungal Infections in Hospitalized Patients with COVID-19 and actors Associated with Healthcare-associated Infections. Open Forum infectious Diseases. ofab201. https://doi.org/10.1093/ofid/ofab201
Maini, A., Tomar, G., Khanna, D., et al. (2021). Sino-orbital mucormycosis in a COVID-19 patient: A case report. Int J Surg Case Rep. https://doi: 10.1016/j.ijscr.2021.105957. Epub 2021 May 4. PMID: 33964720; PMCID: PMC8093005.
Mehta, S. & Pandey, A. (2020). Rhino-Orbital Mucormycosis Associated With COVID-19. Cureus. https://doi: 10.7759/cureus.10726. PMID: 33145132; PMCID: PMC7599039.
Mekonnen, Z.K., Ashraf, D.C., Jankowski, T., et al. (2021). Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome. Ophthalmic Plast Reconstr Surg. https://doi: 10.1097/IOP.0000000000001889. PMID: 33229953; PMCID: PMC7927902.
Moher, D., Liberati, A., Tetzlaff, J., et al. (2009). The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097.
Moorthy, A., Gaikwad, R., Krishna, S., et al. (2021). SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis. J Maxillofac Oral Surg. https://doi: 10.1007/s12663-021-01532-1. Epub ahead of print. PMID: 33716414; PMCID: PMC7936599.
Nehara, H.R., Puri, I., Singhal, V., et al. (2021). Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the northwestern part of India. Indian J Med Microbiol. https://doi: 10.1016/j.ijmmb.2021.05.009. Epub ahead of print. PMID: 34052046; PMCID: PMC8153224.
Ouzzani, M., Hammady, H., Fedorowicz, Z., et al. (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev. https://doi: 10.1186/s13643-016-0384-4.
Pandiar, D., Kumar, N. S., Anand, R., Kamboj, M. & Narwal, A. (2021). Does COVID 19 generate a milieu for propagation of mucormycosis? Medical Hypotheses. v.152. Elsevier.
Reed, C., Bryant, R., Ibrahim, A.S., et al. (2008). Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. https://doi: 10.1086/589857. PMID: 18558882; PMCID: PMC2793535.
Saldanha, M., Reddy, R. & Vincent, M.J. (2021). Paranasal Mucormycosis in COVID-19 Patient. Indian J Otolaryngol Head Neck Surg. 2021 Apr 22:1-4. https://doi: 10.1007/s12070-021-02574-0. Epub ahead of print. PMID: 33903850; PMCID: PMC8060684.
Sen, M., Lahane, S., Lahane, TP., et al.. (2021). Mucor in a Viral Land: A Tale of Two Pathogens. Indian J Ophthalmol. https://doi: 10.4103/ijo.IJO_3774_20. PMID: 33463566; PMCID: PMC7933891.
Singh, A. K., Singh, R. & Joshi, S. R. (2021). A Misra. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes & Metabolic Syndrome. Elsevier.
Song, G., Liang, G. & Liu, W. (2020). Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia. https://doi: 10.1007/s11046-020-00462-9. Epub 2020 Jul 31. PMID: 32737747; PMCID: PMC7394275.
The Joanna Briggs Institute – JBI. (2015). Joanna Briggs Institute Reviewers’ Manual edition/supplement, Australia.
Veisi, A., Bagheri, A., Eshaghi, M., et al. (2021). Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. https://doi: 10.1177/11206721211009450. Epub ahead of print. PMID: 33843287.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Juliana Carvalho Rocha Alves da Silva; Grasiela Piuvezam; Artur Felipe Siqueira de Brito
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
